According to VCBeat, Jiangsu Breath Medical Technology Co., LTD. (Breath Medical) announced the completion of a tens of million yuan Pre-A round of financing, led by Beijing Qinke Tongrun Technology Investment Co. LTD (Tongrun Technology Investment), with the exclusive financial advisor Chana Capital. After this round of financing, Breath Medical will accelerate the clinical trials of its two core products, including "low-temperature plasma radiofrequency surgery system" and "fully degradable sinus drug stent", as well as the development, production, and testing of new products.
Founded in 2017, Breath Medical focuses on the research and development of otolaryngology products, with self-developed consumables and equipment. The company provides overall solutions for otolaryngology surgery.
Fully degraded sinus implants are mainly suitable for the treatment of patients with chronic rhinitis. Traditional endoscopic sinus surgery is likely to lead to postoperative complications such as nasal bleeding, adhesion, and polyps, which seriously affect the effect of surgery. The fully degraded sinus implants provided by Breath Medical can effectively prevent the above situations, maintain the opening and locally deliver drugs after sinus surgery, and completely cure the disease.
Up to now, Breath Medical has accepted 10 invention patents and 7 utility model patents. The company is cooperating with well-known hospitals in China such as Peking Union Medical College Hospital, Chinese PLA General Hospital and Xinhua Hospital Affiliated To Shanghai Jiaotong University School Of Medicine.
About Tongrun Technology Investment
Tongrun Technology Investment focuses on the transformation and investment of high-tech achievements. Based on professional researches of advanced scientific and technological achievements and market demand, the company cooperates with domestic and foreign colleges and universities, searching for high-quality projects at home and abroad. Through an innovative transformation model, Tongrun Technology Investment integrates scientific researches, capital, business, and government resources, to realize the transition and the industrialization of scientific and technological products.